Search
Search Results
##search.searchResults.foundPlural##
-
TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.
1928PDF: 793HTML: 547 -
THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
2685PDF: 763HTML: 2320 -
Interstitial pneumonia triggered by H1N1 influenza A virus as the initial presentation of chronic myeloid leukemia
906PDF: 508HTML: 214Suppl. Files: 335 -
CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment
1782PDF: 868HTML: 458 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
2017PDF: 962HTML: 704 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3485PDF: 1320HTML: 1939Fig.1: 223Fig. 2: 221 -
Guest Editor: Raffaella Origa IRON TOXICITY AND HEMOPOIETIC CELL TRANSPLANTATION: TIME TO CHANGE THE PARADIGM. IRON TOXICITY AND HEMOPOIETIC CELL TRANSPLANTATION
1978PDF: 1236HTML: 253 -
EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES
2269PDF: 837HTML: 1640Figure 1: 208Table 1: 225 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2575PDF: 960HTML: 324 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7743PDF: 2456HTML: 1745Table 1.: 227Table 2.: 239Table 3.: 222Table 4.: 216 -
Lymphomatoid Granulomatosis of Central Nervous System and Lung Driven by Epstein Barr Virus Proliferation: Successful Treatment with Rituximab
1650PDF: 904HTML: 3161Figure 5: 160Figure 4: 162Figure 3: 197Figure 1: 177Figure 2: 173 -
Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy
1214PDF: 775HTML: 1496Figure 1: 196Figure 2: 199 -
DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA
3031PDF: 1609HTML: 240 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3759PDF: 1643HTML: 83 -
PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma
2510HTML: 287PDF: 919 -
GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS Gilteritinib (XOSPATA ®) in Turkey
1498PDF: 922Suppl. Files: 462HTML: 248 -
PREVENTION OF ? THALASSEMIA IN NORTHERN ISRAEL - A COST-BENEFIT ANALYSIS.
2809PDF: 1263HTML: 11813 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1624PDF: 644HTML: 632 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3716PDF: 913HTML: 6729 -
FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.
3360PDF: 1268HTML: 2216 -
Leukocyte derived chemotaxin 2 (ALECT2) amyloidosis
1641PDF: 795HTML: 1314 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3287PDF: 1040HTML: 2134 -
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells
1001PDF: 1232HTML: 117







